APA (7th ed.) Citation

I, F., Z, I., A, d. V., M, R., EF, V., JG, O., . . . MÁ, G. (2025). Association of serum myeloperoxidase with metabolic syndrome and adverse lipid profiles in scleroderma patients. Clinical and experimental rheumatology, 43(8), 1465. https://doi.org/10.55563/clinexprheumatol/nuevmp

Chicago Style (17th ed.) Citation

I, Ferraz-Amaro, Ibrahim-Achi Z, de Vera-González A, Renuncio-García M, Vicente-Rabaneda EF, Ocejo-Vinyals JG, Castañeda S, and González-Gay MÁ. "Association of Serum Myeloperoxidase with Metabolic Syndrome and Adverse Lipid Profiles in Scleroderma Patients." Clinical and Experimental Rheumatology 43, no. 8 (2025): 1465. https://doi.org/10.55563/clinexprheumatol/nuevmp.

MLA (9th ed.) Citation

I, Ferraz-Amaro, et al. "Association of Serum Myeloperoxidase with Metabolic Syndrome and Adverse Lipid Profiles in Scleroderma Patients." Clinical and Experimental Rheumatology, vol. 43, no. 8, 2025, p. 1465, https://doi.org/10.55563/clinexprheumatol/nuevmp.